Nidogens are therapeutic targets for the prevention of tetanus

Science

Volumn 346, Issue 6213, 2014, Pages 1118-1123

  Bercsenyi, Kinga ^a,b   Schmieg, Nathalie ^a,b   Bryson, J Barney ^b   Wallace, Martin ^a,b   Caccin, Paola ^c   Golding, Matthew ^a,e   Zanotti, Giuseppe ^c   Greensmith, Linda ^b   Nischt, Roswitha ^d   Schiavo, Giampietro ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF COLOGNE   (Germany)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENTACTIN; NEUROTOXIN; TETANUS NEUROTOXIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; METALLOPROTEINASE; PEPTIDE; PROTEIN BINDING; TETANOSPASMIN; TETANUS TOXIN;

NEUROLOGY; PROTEIN; TETANUS; TOXIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GAIT DISORDER; IN VIVO STUDY; INFECTION PREVENTION; INTERNALIZATION; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NERVE CELL; NEUROMUSCULAR SYNAPSE; NEUROPROTECTION; NONHUMAN; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; SPASTIC PARESIS; SYNAPSE VESICLE; TETANUS; TIBIALIS ANTERIOR MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENETICS; INBRED MOUSE STRAIN; METABOLISM; MOTONEURON;

MUS;

ANIMALS; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED STRAINS; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TETANUS; TETANUS TOXIN;

EID: 84914680543     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1258138     Document Type: Article

References (30)

1. C. Montecucco, Curr. Top. Microbiol. Immunol. 195, 278 (1995).
2. K. Deinhardt et al., Neuron 52, 293-305 (2006).
3. C. Chen, Z. Fu, J. J. P. Kim, J. T. Barbieri, M. R. Baldwin, J. Biol. Chem. 284, 26569-26577 (2009).
4. S. Jayaraman, S. Eswaramoorthy, D. Kumaran, S. Swaminathan, Proteins 61, 288-295 (2005).
5. Q. Chai et al., Nature 444, 1096-1100 (2006).
6. R. Jin, A. Rummel, T. Binz, A. T. Brunger, Nature 444, 1092-1095 (2006).
7. R. P. A. Berntsson, L. Peng, L. M. Svensson, M. Dong, P. Stenmark, Structure 21, 1602-1611 (2013).
8. R. P. A. Berntsson, L. Peng, M. Dong, P. Stenmark, Nat. Commun. 4, 2058 (2013).
9. M. Dong et al., Science 312, 592-596 (2006).
10. L. Peng, W. H. Tepp, E. A. Johnson, M. Dong, PLOS Pathog. 7, e1002008 (2011).
11. R. M. Benoit et al., Nature 505, 108-111 (2014).
12. K. Mann et al., EMBO J. 8, 65-72 (1989).
13. M. S. Ho, K. Böse, S. Mokkapati, R. Nischt, N. Smyth, Microsc. Res. Tech. 71, 387-395 (2008).
14. J. Kruegel, N. Miosge, Cell. Mol. Life Sci. 67, 2879-2895 (2010).
15. L. Dong et al., Lab. Invest. 82, 1617-1630 (2002).
16. A. Rummel, S. Bade, J. Alves, H. Bigalke, T. Binz, J. Mol. Biol. 326, 835-847 (2003).
17. T. Binz, A. Rummel, J. Neurochem. 109, 1584-1595 (2009).
18. C. Montecucco, Trends Biochem. Sci. 11, 314-317 (1986).
19. A. Rummel et al., Proc. Natl. Acad. Sci. U.S.A. 104, 359-364 (2007).
20. M. A. Fox, M. S. Ho, N. Smyth, J. R. Sanes, Neural Dev. 3, 24 (2008).
21. B. L. Bader et al., Mol. Cell. Biol. 25, 6846-6856 (2005).
22. S. Mahrhold, A. Rummel, H. Bigalke, B. Davletov, T. Binz, FEBS Lett. 580, 2011-2014 (2006).
23. O. Suwan-apichon et al., Invest. Ophthalmol. Vis. Sci. 47, 133-139 (2006).
24. L. Restani et al., PLOS Pathog. 8, e1003087 (2012).
25. M. Matsuda, N. Sugimoto, K. Ozutsumi, T. Hirai, Biochem. Biophys. Res. Commun. 104, 799-805 (1982).
26. F. L. Yeh et al., PLOS Pathog. 6, e1001207 (2010).
27. M. M. Martino et al., Science 343, 885-888 (2014).
28. L. Macri, D. Silverstein, R. A. Clark, Adv. Drug Deliv. Rev. 59, 1366-1381 (2007).
29. E. Stryker, K. G. Johnson, J. Cell Sci. 120, 3723-3728 (2007).
30. P. O'Grady, T. C. Thai, H. Saito, J. Cell Biol. 141, 1675-1684 (1998).